HR+/HER2+ Breast Cancer
35 clinical trials · Condition
◉ Watch HR+/HER2+ Breast Cancer
| Record | Firm | Date |
|---|---|---|
| A Study of BPI-1178 in Patients With Advanced Solid Tumor and HR+/HER2- Breast Cancer (NCT04282031) | Beta Pharma (Suzhou) Co., Ltd. | 2020-06-15 |
| A Dose Escalation and Cohort Expansion Study of NKTR-214 in Combination With Nivolumab and Other Anti-Cancer Therapies in Patients With Select Advanced Solid Tumors (NCT02983045) | Nektar Therapeutics | 2016-12-19 |
Track HR+/HER2+ Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.